Our members make us

Founding Director of the Institute for Aging Research at the Nathan Shock Center of Excellence in the Basic Biology of Aging. Director of the Paul F. Glenn Center for the Biology of Human Aging Research at Albert Einstein College of Medicine.

Co-Founder of Beyond Aging, an organization dedicated to growing the funding environment for longevity research, and CEO of Helpwear, a medical device company building emergency cardiac monitoring devices.

Scientist and entrepreneur known for his discoveries in biophysics and for creating the world's smallest personal computer. CEO of Retro Biosciences.

CEO and co-founder at BioAge, a biotechnology company that discovers and develops drugs that treat aging and age-related diseases.

Vice President of Research, Aging and Age-Related Diseases, at Regeneron Pharmaceuticals, Senior Lecturer in Cell Biology at Harvard Medical School, and Adjunct Professor at Columbia University

Founder of the Forever Healthy Foundation and owner of Kizoo Technology Ventures.

Stephen Helliwell B.Sc. Ph.D. is Vice President Discovery Biology at Rejuveron Life Sciences AG. He manages the biology of multiple drug discovery programs in the healthy aging space, and oversees the biology side of diligence for novel programs .

Serial biotechnology entrepreneur currently the Co-Founder and CEO of Lygenesis, an organ regeneration company.

Director of National University Health System [NUHS) Centre for Healthy Ageing, Singapore. The former President and CEO of the Buck Institute for Research on Aging.

CEO of Hevolution Foundation, Executive Chairman of Life Biosciences. Dr. Khan previously served as Global Vice Chairman and CSO of PepsiCo.

Dr. Joan Mannick is the Co-Founder and CEO of Tornado Therapeutics. Prior to joining Tornado, Dr. Mannick was Head of Research and Development at Life Biosciences, a biotechnology company advancing treatments for age-related diseases by targeting aging biology.

Jerry McLaughlin is Chief Executive Officer and board member of Life Biosciences, Inc. He has over 30 years of experience in the biopharmaceutical industry and has been involved in the discovery, clinical development, and global commercialization of more than a dozen FDA-approved drugs with multiple successful exits.

Biotech investor and entrepreneur, author. Co-founder of Juvenescence and other successful ventures focused on longevity, biotech, and clean food.

Robin Mansukhani is the CEO and Co-Founder of Deciduous Therapeutics, a venture-backed start-up developing novel immunotherapies to treat age related diseases. He also been an advisor to several early stage biotech companies in the Aging and CNS space including Therini Bio and Reservoir Neurosciences.

Founder and CEO of Cambrian Biopharma, a Distributed Drug Discovery Company developing therapeutics targeting the biology of aging.

Co-Founder & Managing Director at Apollo Health Ventures, a venture capital fund that invests in early-stage biotech and aging biology companies.

Co-Founder and CEO of Oviva Therapeutics, Director of Women's Health at Cambrian Biopharma.

Co-Director of Harvard Medical School's Paul F. Glenn Center for Biology and Aging, known for research on aging with a focus on epigenetics. Chosen as one of Time magazine's 50 most influential people in healthcare. Board Member of Live Biosciences

CEO and President of the Buck Institute for Research on Aging and Professor of Medicine at the University of California, San Francisco.

Longevity investor with a mission to extend healthy lifespans of one billion people. Founder of Longevity Vision Fund. Innovation Board Member at XPRIZE Foundation, Development Sponsor of Age Reversal XPRIZE.

Current Founder and CEO of Insilico Medicine, and founder and former CEO of Deep Longevity.